AMOXICILLIN AND BETA-LACTAMASE INHIBITOR , CEFEPIME , CEFOTAXIME, SPIRAMYCIN , PIPERACILLIN AND BETA-LACTAMASE INHIBITOR
APHP210085
Approved small_molecule active
Quick answer
AMOXICILLIN AND BETA-LACTAMASE INHIBITOR , CEFEPIME , CEFOTAXIME, SPIRAMYCIN , PIPERACILLIN AND BETA-LACTAMASE INHIBITOR for EA-COPD (with mechanical ventilation, invasive or non-invasive, or high-flow nasal oxygen therapy). is a Approved program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- EA-COPD (with mechanical ventilation, invasive or non-invasive, or high-flow nasal oxygen therapy).
- Phase
- Approved
- Modality
- small_molecule
- Status
- active